On 24 Mar 2009, at 13:49, eric neumann wrote:
I think this discussion has been quite useful and important, since
there are some remaining issues to be clarified by this community.
I think all points raised are good, but not equally valid. Bijan
and Phil's thoughts are very useful for me, and would probably
resonate within the informatics groups at pharma companies.
I think a key guidance principle here is to ensure that whatever is
proposed "makes sense and works with molecular
biologists" (scientists). Perhaps existing information resources
need a major "enhancement" in order to work in a semantic web, but
then let's make it quite clear (to all possible users) what the
readily perceivable value of all these ontological adjustments will
be.
BTW, I'm perfectly happy, albeit not until summer, to do various
sorts of empirical research to help ground this discussion. I've done
surveys fo the web and user studies before. I would be interested in
knowing what sorts of questions would help people make decisions.
In this sense I *am* all about the data :)
Cheers,
Bijan.
